Alex Toker
 | This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (October 2021) |
Prof. Alex Toker | |
|---|---|
| Alma mater | |
| Scientific career | |
| Fields | Biology, cell biology, apoptosis, Cancer |
| Institutions | |
Alex Toker is currently a professor at the Department of Pathology at Beth Israel Deaconess Medical Center, Harvard Medical School and Chief of the Division of Signal Transduction and Associate Director of the Cancer Research Institute in the Cancer Center.[1][2] His research focus on understanding mechanism of cancer including tumor cell survival, invasion and metastasis. He is currently editor-in-chief of the Journal of Biological Chemistry.[3][4]
References[]
- ^ "Home". www.tokerlab.com. Retrieved August 7, 2021.
- ^ "Alex Toker | Harvard Catalyst Profiles | Harvard Catalyst". connects.catalyst.harvard.edu. Retrieved August 7, 2021.
- ^ "Journal of Biological Chemistry names new editor-in-chief". www.asbmb.org. Retrieved August 7, 2021.
- ^ "Journal of Biological Chemistry". www.jbc.org. Retrieved August 7, 2021.
Authority control  |
|
|---|
   | This biographical article related to medicine in the United States is a stub. You can help Wikipedia by . |
Categories:
- American pathologists
- Living people
- Cancer researchers
- Harvard Medical School faculty
- Academic journal editors
- Alumni of the University of London
- American medical biography stubs